Ferrari MD, et al. Sustained Reduction of Migraine Headache Days in Patients With Episodic Migraine During Months 4 to 6 of Treatment With Galcanezumab. IHC-PO-145. IHC 2019, 5-8 sept. Dublin, Ierland.
Dementie Update 2020
okt 2020 | Dementie
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen
aug 2021 | Hoofdpijn